NCT05131113

Brief Summary

Multicenter randomized controlled trial. Patients will be randomly assigned to the control group or the intervention group in each of the health centers. The control group will receive the usual care, while the intervention group will add an individualized physical exercise program to the usual care. Cancer is a disease of the elderly. More than 65% of all malignancies affect this population. At the same time, the incidence of cancer cases increases and the need to better understand the biological characteristics of the disease, as well as those of the elderly who suffer from it, is highlighted. Oncogeriatrics is the area that addresses the care of the elderly patient with cancer, taking into account that physiological aging causes older people to have their own characteristics that require a differential approach in care. The low inclusion in clinical trials of elderly patients and the few specific trials carried out in this subpopulation together with the progressive aging of the population mean that the development of this area has become a priority in health policies. Therefore, there is a need to focus the research area on supervised physical exercise in older people with cancer in an innovative way, with the aim of generating new hypotheses that overcome existing limitations and facilitate the introduction into the health system of this type of interventions.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
186

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jan 2022

Typical duration for not_applicable

Geographic Reach
1 country

3 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 29, 2021

Completed
4 months until next milestone

First Posted

Study publicly available on registry

November 23, 2021

Completed
2 months until next milestone

Study Start

First participant enrolled

January 27, 2022

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2024

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 3, 2024

Completed
Last Updated

August 20, 2024

Status Verified

June 1, 2023

Enrollment Period

1.9 years

First QC Date

July 29, 2021

Last Update Submit

August 19, 2024

Conditions

Keywords

fragilityphysical exercisebiomarkersoncogeriatrics

Outcome Measures

Primary Outcomes (1)

  • Short Physical Performance Battery

    Short Physical Performance Battery (SPPB) evaluates balance, gait ability, and leg strength using a single tool. The score for each part is given in categorical modality (0-4). The best score will be 12 points. 1 point of change in the total score has demostrated to be of clinical relevance.

    12 weeks

Secondary Outcomes (47)

  • Integral Geriatric Assessment -Socio-familial situation:

    12 weeks

  • Integral Geriatric Assessment - Basic Activities of Daily Living ( BADL):

    12 weeks

  • Integral Geriatric Assessment -Instrumental Activities of Daily Living (IADL):

    12 weeks

  • Integral Geriatric Assessment -Cognitive function:

    12 weeks

  • Integral Geriatric Assessment - Depression:

    12 weeks

  • +42 more secondary outcomes

Study Arms (2)

Control group

NO INTERVENTION

The control group will receive the usual care and hygiene recommendations of the movement

Interventionist group

EXPERIMENTAL

The interventional group will add an individualized physical exercise program to the usual care.

Other: Physical exercise

Interventions

Physical exercise

Interventionist group

Eligibility Criteria

Age70 Years - 100 Years
Sexall
Healthy VolunteersNo
Age GroupsOlder Adult (65+)

You may qualify if:

  • Patients aged 70 or over.
  • Solid cancer.
  • Candidates for systemic treatment (chemotherapy, hormone therapy, biological therapies or immunotherapy) if the time that has elapsed since the last dose of treatment has been at least 1 month (washout period).
  • Patients with breast, gynecological, lung, pleural, digestive, urological, ENT area, sarcomas, brain tumors, melanomas and patients with tumors of unknown origin will be included.Regarding tumor type and stage for patients with lymphoma: 1) Diffuse large B-cell NHL: include stages I-II if Bulky (\>7.5 cm) or R-IPI\>1. 2) Hodgkin lymphoma: stages I-II if Bulky (\>10 cm). 3) Follicular NHL and marginal NHL without GELF treatment criteria. 4) 80 years old receiving 6 R-mini CHOP cycles.

You may not qualify if:

  • ECOG ≥3
  • cases of advanced dementia
  • serious psychiatric illnesses
  • Lack of basic fluency in the Basque or Spanish language
  • those patients unable to get up from the chair and walk independently with or without auxiliary device.
  • Neither will those patients who participate in other studies in which they are undertaking a physical exercise program be included.
  • Absolute or relative contraindications in which the risk of adverse effects outweighs the possible benefits such as unstable angina, acute symptomatic heart failure ...

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

Hospital Universitario Donostia

San Sebastián, Guipuzcoa, 20014, Spain

Location

Hospital Universitario Basurto

Bilbao, 48013, Spain

Location

Hospital Universitario de Araba

Vitoria-Gasteiz, Álava, 01009, Spain

Location

Related Publications (1)

  • Garcia-Garcia J, Rodriguez-Larrad A, de Rituerto Zeberio MM, Mediavilla JG, Vicente BL, Artola NT, Etxetxipia IZ, Garmendia I, Alberro A, Otaegui D, Rabasco FB, Caffarel MM, Vrotsou K, Irazusta J, Arrieta H, Pelaez M, Belloso J, Basterretxea L. Effects of a 12-week multicomponent exercise programme on physical function in older adults with cancer: Study protocol for the ONKO-FRAIL randomised controlled trial. J Geriatr Oncol. 2025 Dec 5;17(2):102818. doi: 10.1016/j.jgo.2025.102818. Online ahead of print.

MeSH Terms

Conditions

NeoplasmsMotor Activity

Interventions

Exercise

Condition Hierarchy (Ancestors)

Behavior

Intervention Hierarchy (Ancestors)

Motor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 29, 2021

First Posted

November 23, 2021

Study Start

January 27, 2022

Primary Completion

January 1, 2024

Study Completion

May 3, 2024

Last Updated

August 20, 2024

Record last verified: 2023-06

Locations